Ionis Pharmaceuticals, Inc. (IONS)
62.03
+2.29
(+3.83%)
USD |
NASDAQ |
Aug 24, 16:00
61.98
-0.05
(-0.08%)
After-Hours: 20:00
Ionis Pharmaceuticals Price : 62.03 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 59.64 | 60.92 | 59.06 | 59.74 | 2.724M |
| Aug 20, 2026 | 60.02 | 60.41 | 58.60 | 58.76 | 2.125M |
| Aug 19, 2026 | 60.11 | 61.36 | 59.61 | 60.80 | 3.138M |
| Aug 18, 2026 | 58.40 | 60.19 | 58.02 | 59.62 | 3.193M |
| Aug 17, 2026 | 57.11 | 58.74 | 56.41 | 58.63 | 2.000M |
| Aug 14, 2026 | 55.16 | 57.24 | 55.16 | 57.24 | 1.354M |
| Aug 13, 2026 | 56.50 | 56.81 | 55.56 | 55.87 | 1.220M |
| Aug 12, 2026 | 55.01 | 57.06 | 54.91 | 56.53 | 2.000M |
| Aug 11, 2026 | 56.79 | 57.16 | 55.37 | 55.42 | 2.407M |
| Aug 10, 2026 | 56.10 | 57.66 | 56.10 | 56.94 | 2.400M |
| Aug 07, 2026 | 54.73 | 56.60 | 54.40 | 56.56 | 2.009M |
| Aug 06, 2026 | 54.59 | 55.42 | 54.02 | 54.49 | 2.592M |
| Aug 05, 2026 | 55.17 | 55.36 | 53.58 | 54.19 | 2.122M |
| Aug 04, 2026 | 54.85 | 55.22 | 53.87 | 55.07 | 2.688M |
| Aug 03, 2026 | 52.66 | 54.54 | 52.16 | 54.49 | 3.213M |
| Jul 31, 2026 | 53.32 | 53.32 | 51.28 | 51.77 | 2.571M |
| Jul 30, 2026 | 53.92 | 54.04 | 52.65 | 53.28 | 2.875M |
| Jul 29, 2026 | 55.08 | 55.36 | 53.50 | 54.04 | 3.129M |
| Jul 28, 2026 | 56.56 | 56.56 | 54.00 | 55.30 | 2.805M |
| Jul 27, 2026 | 56.92 | 57.09 | 55.79 | 55.96 | 2.585M |
| Jul 24, 2026 | 56.32 | 57.36 | 56.18 | 56.55 | 3.095M |
| Jul 23, 2026 | 53.71 | 57.48 | 53.35 | 55.87 | 3.834M |
| Jul 22, 2026 | 51.16 | 54.06 | 50.00 | 54.01 | 8.733M |
| Jul 21, 2026 | 52.75 | 54.13 | 52.26 | 53.39 | 3.074M |
| Jul 20, 2026 | 54.47 | 54.80 | 52.82 | 52.95 | 2.167M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.06 |
| Biogen, Inc. | 218.11 |
| BridgeBio Pharma, Inc. | 81.05 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Arrowhead Pharmaceuticals, Inc. | 86.74 |
Price Related Metrics
| PS Ratio | 11.57 |
| PEG Ratio | -0.2040 |
| Price to Book Value | 23.36 |
| Earnings Yield | -5.60% |
| Market Cap | 10.27B |
| PEGY Ratio | -0.2040 |